Drug mechanism‐of‐action discovery through the integration of pharmacological and CRISPR screens

Related articles

1. CellEKT: A robust chemical proteomics workflow to profile cellular target engagement of kinase inhibitors

   This article has 22 authors:

   1. Joel Rüegger
   2. Berend Gagestein
   3. Antonius P. A. Janssen
   4. Alexandra Valeanu
   5. Alger Lazo Mori
   6. Marielle van der Peet
   7. Michael S. Boutkan
   8. Bogdan I. Florea
   9. Alex A. Henneman
   10. Remo Hochstrasser
   11. Haiyan Wang
   12. Paul Westwood
   13. Andreas Topp
   14. Patricia M. Gomez Barila
   15. Jan Paul Medema
   16. Connie R. Jimenez
   17. Bigna Woersdoerfer
   18. Stephan Kirchner
   19. Jitao David Zhang
   20. Uwe Grether
   21. Arne C. Rufer
   22. Mario van der Stelt

2. Quantifying Cancer Drug Targetability across Biochemical Pathways

   This article has 1 author:

   1. Stuart Hagler

3. Pharmacoproteomic profiling identifies secreted markers for aberrant drug action

   This article has 10 authors:

   1. Sascha Knecht
   2. Mathias Kalxdorf
   3. Johanna Korbeń
   4. Toby Mathieson
   5. Daniel C. Sevin
   6. Bernhard Kuster
   7. Richard Kasprowicz
   8. Melanie Z. Sakatis
   9. H. Christian Eberl
   10. Marcus Bantscheff